Headache in the Neurological Emergency Department-High Degree of Inadequate Documentation Calls for Structured Assessments
- PMID: 35401419
- PMCID: PMC8987986
- DOI: 10.3389/fneur.2022.847484
Headache in the Neurological Emergency Department-High Degree of Inadequate Documentation Calls for Structured Assessments
Abstract
Headaches are a frequent reason for presentation to the emergency department (ED) and can pose a great challenge for the attending physicians. First and foremost, the distinction between a primary and secondary headache with potentially life-threatening implications can be difficult. Moreover, it often occurs that no specific headache diagnosis is made at discharge from the ED. Therefore, in this present retrospective cross-sectional study, all patients who presented to the emergency department of the Department of Neurology at Rostock University Medical Centre with the main symptom of headache between November 2013 and November 2016 underwent a neurological examination and the extent to which warning symptoms ("red flags") for a secondary headache as well as symptoms necessary for a correct headache diagnosis according to the ICHD-3 classification were recorded and documented. We could show that documentation of red flags and clinical characteristics is inadequate and does not allow proper diagnostic categorization. To facilitate concise documentation and rapid decision making we suggest a structured and standardized form for documenting the headache history and red flags in the ED.
Keywords: (ICHD-3) International Classification of Headache Disorders; documentation; emergency department (ED); headache; migraine; red flags; structured assessment; third edition.
Copyright © 2022 Rimmele, Janke, Kropp, Kasch, Walter and Jürgens.
Conflict of interest statement
FR served on advisory boards and/or as speaker for Allergan, Novartis, Teva, Ipsen, Lilly. He has received royalties from Elsevier. PK served on advisory boards and/or as speaker for Allergan, Novartis, Teva, and Lilly. UW has received speaker honoraria and travel funds from Ipsen Pharma, Merz Pharma, Allergan, Bristol-Myers Squibb, Daiichi Sankyo, Bayer Vital, Boehringer Ingelheim and Pfizer, and a research grant from Merz Pharma. He has received royalties from Thieme and Elsevier Press. He serves as editor of the European Journal of Ultrasound. TJ served on advisory boards and/or as speaker for Allergan, Autonomic Technologies, Desitin, Hormosan, Novartis, Lilly, Lundbeck, Sanofi, and Teva. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Headache at the emergency room: Etiologies, diagnostic usefulness of the ICHD 3 criteria, red and green flags.PLoS One. 2019 Jan 7;14(1):e0208728. doi: 10.1371/journal.pone.0208728. eCollection 2019. PLoS One. 2019. PMID: 30615622 Free PMC article.
-
Applying the International Classification of Headache Disorders to the emergency department: an assessment of reproducibility and the frequency with which a unique diagnosis can be assigned to every acute headache presentation.Ann Emerg Med. 2007 Apr;49(4):409-19, 419.e1-9. doi: 10.1016/j.annemergmed.2006.11.004. Epub 2007 Jan 8. Ann Emerg Med. 2007. PMID: 17210203
-
Headache Characteristics in the Neurological Emergency Department: A Retrospective Study.Front Neurol. 2021 Aug 19;12:706074. doi: 10.3389/fneur.2021.706074. eCollection 2021. Front Neurol. 2021. PMID: 34489852 Free PMC article.
-
Management of Childhood Headache in the Emergency Department. Review of the Literature.Front Neurol. 2019 Aug 23;10:886. doi: 10.3389/fneur.2019.00886. eCollection 2019. Front Neurol. 2019. PMID: 31507509 Free PMC article. Review.
-
Emergency Department and Inpatient Management of Headache in Adults.Curr Neurol Neurosci Rep. 2020 Mar 18;20(4):7. doi: 10.1007/s11910-020-01030-w. Curr Neurol Neurosci Rep. 2020. PMID: 32189074 Review.
References
LinkOut - more resources
Full Text Sources